You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 11, November 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Anthralin in the Treatment of Alopecia Areata

Virginia C. Fiedler-Weiss, MD; Cunera M. Buys, MS

Arch Dermatol. 1987;123(11):1491-1493.


Abstract

• Anthralin cream 0.5% to 1.0% was used to treat 68 patients with severe alopecia areata. Therapy was relatively well tolerated, although all patients experienced pruritus and local erythema and scaling. Cosmetic response was seen in 17 (25%) of the patients, and was maintained during therapy in 12 (71%) of the 17 cosmetic responders. For the patients treated with 0.5% anthralin, the mean time to response (44 of 66 patients) was 11 weeks; the mean time to cosmetic response (13 of 66 patients) was 23 weeks. Duration of the current episode of hair loss did not correlate with cosmetic response. Compared with other currently available topical treatments, anthralin appears to be a reasonable therapeutic option for severe alopecia areata.

(Arch Dermatol 1987;123:1491-1493)



Author Affiliations

From the Department of Dermatology, University of Illinois College of Medicine, Chicago.


Footnotes

Accepted for publication May 7, 1987.

Presented in part at the Annual Meeting of the American Academy of Dermatology, New Orleans, Dec 9, 1986.

Reprint requests to Department of Dermatology (M/C 624), University of Illinois College of Medicine at Chicago, PO Box 6998, Chicago, IL 60690 (Dr Fiedler-Weiss).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Hair Loss
Price
NEJM 1999;341:964-973.
FULL TEXT  

Alopecia Areata: A Review of Therapy, Efficacy, Safety, and Mechanism
Fiedler
Arch Dermatol 1992;128:1519-1529.
ABSTRACT  

Treatment-Resistant Alopecia Areata: Response to Combination Therapy With Minoxidil Plus Anthralin
Fiedler et al.
Arch Dermatol 1990;126:756-759.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.